Sustainability | April 17, 2025
Aarti Pharmalabs achieves SBTi approval of GHG emission reduction targets
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
The IND application supports the next phase of development of SBO-154
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The USFDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated
YESINTEK, is intended for the treatment of adults and children with plaque psoriasis and adults with psoriatic arthritis or Crohn's disease
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
OneSource operates five cGMP facilities and has a strong track record, with 138 successful regulatory and customer audits to date by all major regulatory bodies
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Subscribe To Our Newsletter & Stay Updated
